Navigation Links
PhRMA Launches Campaign to Raise Awareness of Success of Medicare Prescription Drug Benefit
Date:6/10/2009

WASHINGTON, June 10 /PRNewswire-USNewswire/ -- With the debate over comprehensive healthcare reform now in full swing, the Pharmaceutical Research and Manufacturers of America is launching a new national broadcast advertising campaign touting the importance and success of free-market initiatives such as the Medicare prescription drug benefit (Part D).

Medicare Part D continues to provide unprecedented coverage and choice for seniors and disabled Americans, according to national surveys. And most importantly, seniors are saving money on their medicines through the program, particularly those who need it the most. According to the Centers for Medicare and Medicaid Services (CMS), the average value of the Part D benefit, premium subsidy, and cost-sharing subsidy in 2009 will be $1,200 for the average beneficiary, and about $3,900 for low-income.

In fact, in 2009, approximately 97 percent of beneficiaries in a stand-alone plan have access to a monthly premium less or equal to the premium they paid in 2008, according to CMS. And every state offers a Medicare prescription drug plan with a premium of $23 or less.

A recent Medicare Today survey, cited in the commercial, shows overall satisfaction has grown from 78 percent at the start of the program in 2006, to 84 percent in 2009. In addition, the new commercial also pushes for comprehensive healthcare reform.

"There is a success story out there in healthcare, and we want people to know about it. Since its inception, the Medicare drug benefit has given beneficiaries unprecedented access to needed medications, at an affordable cost," said PhRMA Senior Vice President Ken Johnson.

Not only are Medicare beneficiaries saving significant money, so too are American taxpayers. In March 2009, the non-partisan Congressional Budget Office (CBO) released new baseline spending projections that reduced its 10-year forecast for the total cost of the Medicare drug program by $520 billion, or 43 percent, compared with its 2006 estimate for the same 10-year period (FY 2007-2016).

"PhRMA echoes the sentiment shared by President Obama and members of Congress that it is critical that all Americans have access to high-quality and affordable healthcare coverage and will do everything we can to help ensure that a comprehensive healthcare reform bill gets to the White House this year," said PhRMA President and CEO Billy Tauzin.

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country's leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $50.3 billion in 2008 in discovering and developing new medicines. Industry-wide research and investment reached a record $65.2 billion in 2008.

PhRMA Internet Address: http://www.phrma.org

For information on stories of hope and survival, visit: http://sharingmiracles.com/

For information on how innovative medicines save lives, visit: http://www.innovation.org

For information on the Partnership for Prescription Assistance, visit: http://www.pparx.org

For more information on public health emergencies, visit http://www.rxresponse.org

For information on the danger of imported drugs, visit:http://www.buysafedrugs.info


'/>"/>
SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. PhRMA Statement on Healthcare Reform Coalition
2. American Slide Chart/Perrygraf "SlideGuides" and "SpinGuides" Help Drug Companies Satisfy New PhRMA Guidelines
3. PhRMA Honors Gardasil(r) Researchers With Discoverers Award
4. AstraZenecas David Brennan Elected PhRMA Board Chairman
5. PhRMA Statement on Expansion of SCHIP
6. DIA/FDA/PhRMA Drug Safety Conference: Planning the Lifecycle of Safety Evaluation
7. Revised PhRMA Marketing Code Calls for More Educational Materials for Health Care Providers and Staff - Anatstat Health Education Can Help
8. Eisai Renews Its Commitment to Responsible Healthcare Community Interactions in Accordance with the Revised PhRMA Marketing Code
9. Johnson & Johnson Announces Commitment To Adopt Revised PhRMA Marketing Code for Responsible Interactions With Healthcare Professionals
10. PhRMA Revised Marketing Code Reinforces Commitment to Responsible Interactions With Healthcare Professionals
11. Richard T. Clark Elected PhRMA Board Chairman
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... Raton, Fl (PRWEB) , ... August 18, 2017 ... ... largest network of highly trained practitioners specializing in bioidentical hormone replacement therapy and ... associated with hormone imbalance and conditions of aging, such as menopause, andropause, thyroid ...
(Date:8/18/2017)... ... August 18, 2017 , ... “Our Mountains to Climb: A Journey ... couple that grew stronger together through the faith they shared to overcome struggles in ... the creation of published author, Barbara J. Corcoran, a retired teacher and happily married ...
(Date:8/18/2017)... New York, New York (PRWEB) , ... August ... ... the world’s leading manufacturers and marketers of high-quality anti-aging skincare solutions, ... Prache Antiaging Serum. These new products are an affordable, yet effective alternative to ...
(Date:8/17/2017)... ... August 17, 2017 , ... Riccobene ... new location in Goldsboro, NC to its family of practices. Residents of Goldsboro ... trademark starting August 15, 2017. , Riccobene Associates Family Dentistry, founded by ...
(Date:8/17/2017)... ... August 17, 2017 , ... ... of three years for its residential drug and alcohol detox program. This accreditation ... organization and shows the organization’s substantial conformance to the CARF standards. , Behavioral ...
Breaking Medicine News(10 mins):
(Date:8/8/2017)... TEL AVIV, Israel, Aug. 8, 2017  BioLineRx Ltd. ... and immunology, today reports its financial results for the ... and achievements during the second quarter 2017 and to ... on multiple clinical development programs for the Company,s lead ... Phase 3 pivotal study with BL-8040 as novel stem ...
(Date:8/7/2017)... 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation,s largest ... June 30, 2017.  All comparisons, unless otherwise noted, are to ... Second Quarter 2017 Highlights include: ... an increase of 3.5% Total prescriptions dispensed ... of 7.5% versus 7.6% Gross profit ...
(Date:8/2/2017)... 2017 Fenita J. Caldwell ... Pinnacle Lifetime Professional in the Field of Healthcare. ... Turing Pharmaceuticals, AG. Her skills and areas of ... ... of experience as a highly successful sales specialist ...
Breaking Medicine Technology: